XML 68 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Cash flows from operating activities:    
Net income $ 148,557 $ 211,589
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 83,617 89,319
Right-of-use asset amortization 142,210  
Provision (benefit) for deferred income taxes 211 (10,168)
Share-based compensation expense 16,807 17,076
Loss on disposition of property and equipment, net 819 2,734
Changes in assets and liabilities:    
Receivables (19,550) (14,664)
Inventory (161,255) (104,569)
Prepaid expenses and other assets (37,228) (17,748)
Payables, accrued expenses and other liabilities 100,534 96,614
Operating lease liabilities (153,320)  
Net cash provided by operating activities 121,402 270,183
Cash flows from investing activities:    
Cash paid for property and equipment (171,121) (89,979)
Cash paid for marketable securities (299,322) (280,153)
Sales and maturities of marketable securities 382,629 211,174
Net cash used in investing activities (87,814) (158,958)
Cash flows from financing activities:    
Proceeds from the exercise of stock options 974 13,618
Share repurchases related to share repurchase program (217,421) (57,512)
Share repurchases related to taxes for share-based awards (5,574) (10,187)
Net cash used in financing activities (222,021) (54,081)
Effect of exchange rate changes on cash and cash equivalents (2,757) (10,343)
(Decrease) increase in cash and cash equivalents (191,190) 46,801
Cash and cash equivalents at beginning of period 358,260 282,220
Cash and cash equivalents at end of period 167,070 329,021
Cash paid during the year for:    
Income taxes 56,910 73,454
Non-cash investing activities—Accrued capital expenditures $ 14,769 $ 13,580